Table 2 |
||||
|
Elevation of IgG antibody titers (≥ 1:160) against Epstein-Barr viral capsid antigen (anti-EB-VCA titer) by IL-10 T-819C genotype, stratified by sex+ |
||||
| IL-10 T-819C Genotype |
Women |
Men |
||
|
|
||||
| Number with anti-EB-VCA IgG titer ≥ 1:160/Total (%) |
Odds ratio of anti-EB-VCA IgG titer ≥ 1:160 (95% CI) |
Number with anti-EB-VCA IgG titer ≥ 1:160/Total (%) |
Odds ratio of anti-EB-VCA IgG titer ≥ 1:160 (95% CI) |
|
|
|
||||
| T/T |
29/54 (53.7) |
1.00 (Reference) |
32/56 (57.1) |
1.00 (Reference) |
| T/C |
38/57 (66.7) |
1.72 (0.80–3.75) |
32/51 (62.7) |
1.26 (0.58–2.76) |
| C/C |
10/12 (83.3) |
4.31 (1.01–29.79) |
5/11 (45.5) |
0.63 (0.16–2.31) |
| P-trend* = 0.037 |
P-trend* = 0.84 |
|||
|
|
||||
|
*Armitage-Cochran Trend Test, adjusted for age +Trend difference between sexes: P = 0.097 |
||||
|
Yasui et al. Journal of Autoimmune Diseases 2008 5:2 doi:10.1186/1740-2557-5-2 |
||||
